These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3855645)

  • 1. The blast crisis of chronic granulocytic leukaemia: a new approach to treatment.
    Schey SA; Greene ML; Ardeman S; Ruddell K
    Br J Haematol; 1985 Jan; 59(1):190-2. PubMed ID: 3855645
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia.
    Winton EF; Miller D; Vogler WR
    Cancer Treat Rep; 1981; 65(5-6):389-92. PubMed ID: 6165470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute myelocytic leukemia.
    Holland JF; Glidewell O; Ellison RR; Corey RW; Schwartz J; Wallace HJ; Hoagland HC; Wiernik P; Rai K; Bekesi JG; Cuttner J
    Arch Intern Med; 1976 Dec; 136(12):1377-81. PubMed ID: 793552
    [No Abstract]   [Full Text] [Related]  

  • 6. SAB--a promising new treatment to improve remission rates in AML in the elderly?
    Wheatley K
    Br J Haematol; 2002 Aug; 118(2):432-3. PubMed ID: 12139727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
    Büchner T; Hiddemann W; Löffler G; Gassmann W; Maschmeyer G; Heit W; Hossfeld D; Weh H; Ludwig WD; Thiel E
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):76-9. PubMed ID: 1780757
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute granulocytic leukemia in adults.
    Frei E
    N Engl J Med; 1972 Jun; 286(22):1211-2. PubMed ID: 4502491
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the treatment of myeloblastic crisis in myelocytic leukemia using the HAR program].
    Zdziechowska H; Niemierko E; Takiel M; Konopka L; Pawelski S
    Acta Haematol Pol; 1986; 17(3-4):91-5. PubMed ID: 3473887
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).
    Weinstein H; Ravindranath Y; Krischer J; Steuber P; Civin C; Gresik M; Vietti T
    Leukemia; 1992; 6 Suppl 2():52-4. PubMed ID: 1578941
    [No Abstract]   [Full Text] [Related]  

  • 14. Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML.
    Anger B; Heimpel H
    Blut; 1989 Jun; 58(6):299-301. PubMed ID: 2660927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 16. High-dose cytarabine induction for acute myeloid leukemia.
    Shepherd JD; Barnett MJ; Philips GL
    Blood; 1996 Jul; 88(2):754-5. PubMed ID: 8695826
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia.
    Siddiqui T; Durkin WJ; Conley NS; Doughney KB; Favis GR; Weiss R; Smith AE
    J Fla Med Assoc; 1994 Jul; 81(7):475-7. PubMed ID: 7964574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
    Zittoun R; Liso V; Mandelli F; Rotoli B; de Witte T; Gattringer C; Resegotti L; Caronia F; Leoni P; Petti MC
    Leukemia; 1992; 6 Suppl 2():76-7. PubMed ID: 1578949
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-cardiotoxic anthracycline regimens in the treatment of acute myeloblastic leukaemia.
    Boughton BJ; Franklin IM; Apperley J; Knight D
    Br J Haematol; 1984 Oct; 58(2):378-80. PubMed ID: 6591946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.